
New Product Launch
SERO is proud to announce the launch of Seronorm® Cardiac Acute Lyo, a new lyophilized quality control material specifically designed to support laboratories in acute cardiac diagnostics.
Developed in close collaboration with clinical laboratories and experts in the field, Seronorm® Cardiac Acute Lyo addresses the growing need for precise and stable control materials covering key acute cardiac markers. The product is tailored to meet the demands of high-performance immunoassay systems used in emergency and intensive care diagnostics.
Key Features:
- Covers critical acute cardiac markers, including Troponin I, Troponin T, CK-MB, and Myoglobin
- Lyophilized format for extended shelf life and easy transport
- High lot-to-lot consistency for reliable performance across instruments and platforms
- Clinically relevant levels that match decision points in acute care
Read more: Here
The launch of Seronorm® Cardiac Acute Lyo strengthens SERO’s position as a trusted provider of quality controls tailored to clinical needs. It also expands the company’s established immunoassay portfolio.